mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
-0.0077 |
0.8 |